ArticleFrontiers in pharmacology2020

Silencing c-Myc Enhances the Antitumor Activity of Bufalin by Suppressing the HIF-1α/SDF-1/CXCR4 Pathway in Pancreatic Cancer Cells.

Xia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.